BRI Vaccine Partnership: The Local Production of Chinese Vaccines and the Future Network of Providing mRNA Vaccines
35 Pages Posted: 20 Jun 2022 Last revised: 23 Jun 2022
Date Written: May 31, 2022
In this report, we will continue to study the impact of global health governance on curbing Covid-19 and trace the vaccine development, especially with regard to the Belt and Road Vaccine Partnership launched by China. The second section synthesizes the current progress of the world in combatting Covid-19. Due to mutations of Covid-19 variants (Delta and Omicron) and disparate vaccination rate among different countries, the third section will summarize challenges to global health governance. The fourth section will make proposals on how to close the vaccine gaps by boosting vaccines supplies and coordinating national policies on the re-opening time schedule.
Funding Information: None.
Conflict of Interests: None.
Keywords: BRI Vaccine Partnership; Global Health Governance
Suggested Citation: Suggested Citation